These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20553495)

  • 41. Can Physicochemical Properties Alter the Potency of Aeroallergens? Part 2 - Impact of Physicochemical Properties.
    Teixeira CSS; Carriço-Sá B; Villa C; Mafra I; Costa J
    Curr Allergy Asthma Rep; 2024 Nov; 24(11):609-617. PubMed ID: 39302572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interplay between Affinity and Valency in Effector Cell Degranulation: A Model System with Polcalcin Allergens and Human Patient-Derived IgE Antibodies.
    Bucaite G; Kang-Pettinger T; Moreira J; Gould HJ; James LK; Sutton BJ; McDonnell JM
    J Immunol; 2019 Oct; 203(7):1693-1700. PubMed ID: 31462504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition.
    Mitropoulou AN; Bowen H; Dodev TS; Davies AM; Bax HJ; Beavil RL; Beavil AJ; Gould HJ; James LK; Sutton BJ
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8707-E8716. PubMed ID: 30150373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity.
    Freier R; Dall E; Brandstetter H
    Sci Rep; 2015 Aug; 5():12707. PubMed ID: 26235974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties.
    Kofler S; Ackaert C; Samonig M; Asam C; Briza P; Horejs-Hoeck J; Cabrele C; Ferreira F; Duschl A; Huber C; Brandstetter H
    J Biol Chem; 2014 Jan; 289(1):540-51. PubMed ID: 24253036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solution structure, dynamics, and hydrodynamics of the calcium-bound cross-reactive birch pollen allergen Bet v 4 reveal a canonical monomeric two EF-hand assembly with a regulatory function.
    Neudecker P; Nerkamp J; Eisenmann A; Nourse A; Lauber T; Schweimer K; Lehmann K; Schwarzinger S; Ferreira F; Rösch P
    J Mol Biol; 2004 Mar; 336(5):1141-57. PubMed ID: 15037075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polcalcin divalent ion-binding behavior and thermal stability: comparison of Bet v 4, Bra n 1, and Bra n 2 to Phl p 7.
    Henzl MT; Davis ME; Tan A
    Biochemistry; 2010 Mar; 49(10):2256-68. PubMed ID: 20143814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
    Hayek B; Vangelista L; Pastore A; Sperr WR; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
    J Immunol; 1998 Dec; 161(12):7031-9. PubMed ID: 9862740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogold electron microscopic localization of the 2 EF-hand calcium-binding pollen allergen Phl p 7 and its homologues in pollens of grasses, weeds and trees.
    Grote M; Westritschnig K; Valenta R
    Int Arch Allergy Immunol; 2008; 146(2):113-21. PubMed ID: 18204277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis for diversity of the EF-hand calcium-binding proteins.
    Grabarek Z
    J Mol Biol; 2006 Jun; 359(3):509-25. PubMed ID: 16678204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs.
    Gifford JL; Walsh MP; Vogel HJ
    Biochem J; 2007 Jul; 405(2):199-221. PubMed ID: 17590154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular metamorphosis in polcalcin allergens by EF-hand rearrangements and domain swapping.
    Magler I; Nüss D; Hauser M; Ferreira F; Brandstetter H
    FEBS J; 2010 Jun; 277(12):2598-610. PubMed ID: 20553495
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.